Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Halfon

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
La Revue De Medecine Interne|December 20, 2025
[Evolution of the nomenclature of steatotic liver diseases: Towards a paradigm shift]Philippe Halfon
Journal of Hepatology|February 3, 2011
Hepatitis C virus resistance to protease inhibitorsPhilippe Halfon, Stephen Locarnini
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?Philippe Halfon, Christoph Sarrazin
Gastroenterologie Clinique Et Biologique|December 17, 2008
FibroTest-ActiTest as a non-invasive marker of liver fibrosisPhilippe Halfon, Mona Munteanu, Thierry Poynard
La Revue De Medecine Interne|September 5, 2024
[SIBO, from myth to reality]Thomas Escoda, Frédérique Retornaz, Anne Plauzolles, et al.
Presse Medicale (Paris, France : 1983)|February 13, 2007
[Noninvasive methods for predicting liver fibrosis in patients with chronic hepatitis C: alternatives to liver biopsy]Philippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
Presse Medicale (Paris, France : 1983)|July 6, 2004
[The diagnostic tools of hepatitis C virus infections]Philippe Halfon, Denis Ouzan, Laurent Cattan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HCV direct-acting antiviral agents: the best interferon-free combinationsRaymond Schinazi, Philippe Halfon, Patrick Marcellin, et al.
European Journal of Medicinal Chemistry|November 26, 2002
Hydration free energy a fragmental model and drug designGérard Pèpe, Gaël Guiliani, Sophie Loustalet, et al.
Cells|July 14, 2023
Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint InhibitorsEloïne Bestion, Eric Raymond, Soraya Mezouar, et al.
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
La Revue De Medecine Interne|December 20, 2025
[Evolution of the nomenclature of steatotic liver diseases: Towards a paradigm shift]Philippe Halfon
Journal of Hepatology|February 3, 2011
Hepatitis C virus resistance to protease inhibitorsPhilippe Halfon, Stephen Locarnini
Liver International : Official Journal of the International Association for the Study of the Liver|January 4, 2012
Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?Philippe Halfon, Christoph Sarrazin
Gastroenterologie Clinique Et Biologique|December 17, 2008
FibroTest-ActiTest as a non-invasive marker of liver fibrosisPhilippe Halfon, Mona Munteanu, Thierry Poynard
La Revue De Medecine Interne|September 5, 2024
[SIBO, from myth to reality]Thomas Escoda, Frédérique Retornaz, Anne Plauzolles, et al.
Presse Medicale (Paris, France : 1983)|February 13, 2007
[Noninvasive methods for predicting liver fibrosis in patients with chronic hepatitis C: alternatives to liver biopsy]Philippe Halfon, Marc Bourlière, Guillaume Pénaranda, et al.
Presse Medicale (Paris, France : 1983)|July 6, 2004
[The diagnostic tools of hepatitis C virus infections]Philippe Halfon, Denis Ouzan, Laurent Cattan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
HCV direct-acting antiviral agents: the best interferon-free combinationsRaymond Schinazi, Philippe Halfon, Patrick Marcellin, et al.
European Journal of Medicinal Chemistry|November 26, 2002
Hydration free energy a fragmental model and drug designGérard Pèpe, Gaël Guiliani, Sophie Loustalet, et al.
Cells|July 14, 2023
Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint InhibitorsEloïne Bestion, Eric Raymond, Soraya Mezouar, et al.
Pageof 16